Cargando…

Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy

Detalles Bibliográficos
Autores principales:	Lee, Young-Ho, Liu, Xiyong, Qiu, Fuming, O’Connor, Timothy R., Yen, Yun, Ann, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395453/ https://www.ncbi.nlm.nih.gov/pubmed/25875848 http://dx.doi.org/10.1371/journal.pone.0124853

Ejemplares similares

HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
por: Lee, Young-Ho, et al.
Publicado: (2015)

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2017)

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
por: Yalon, Michal, et al.
Publicado: (2016)

Correction: HP1gamma function is required for male germ cell survival and spermatogenesis
por: Brown, Jeremy P, et al.
Publicado: (2012)

Correction: Endogenous Retrovirus EAV-HP Linked to Blue Egg Phenotype in Mapuche Fowl
por: Wragg, David, et al.
Publicado: (2013)

Correction: A Novel Insight into the Oxidoreductase Activity of Helicobacter pylori HP0231 Protein
por: Roszczenko, Paula, et al.
Publicado: (2012)

Correction: Endogenous Retrovirus EAV-HP Linked to Blue Egg Phenotype in Mapuche Fowl
Publicado: (2014)

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
por: Giannelli, Gianluigi, et al.
Publicado: (2021)

Correction: The BRCT Domain of PARP-1 Is Required for Immunoglobulin Gene Conversion
por: Paddock, Marcia N., et al.
Publicado: (2018)

Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
por: Yu, Yizhou, et al.
Publicado: (2021)

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
por: Hodgson, Darren R., et al.
Publicado: (2018)

The complete genome and methylome of Helicobacter pylori hpNEAfrica strain HP14039
por: Lamichhane, Binit, et al.
Publicado: (2019)

Role of Biomarkers in the Development of PARP Inhibitors
por: Ganguly, Bratati, et al.
Publicado: (2016)

Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
por: King, David, et al.
Publicado: (2023)

Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
por: Ma, Liying, et al.
Publicado: (2021)

Correction to: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/. BRCA1 DNA damage repair complex in prostate cancer cells
por: Yin, Linglong, et al.
Publicado: (2022)

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Publicado: (2020)

BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme
por: Xavier, Mary-Ann, et al.
Publicado: (2021)

Correction to: Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop
por: Di Napoli, Arianna, et al.
Publicado: (2023)

Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
por: Nitta, Masayuki, et al.
Publicado: (2011)

Correction: Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer
Publicado: (2021)

PARP inhibitors: the race is on
por: Brown, Jessica S, et al.
Publicado: (2016)

Correction to: The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
por: Zamò, Alberto, et al.
Publicado: (2023)

Correction to: PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD(+) levels and increasing SIRT1 activity
por: Zha, Siyuan, et al.
Publicado: (2018)

Correction: Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2013)

Author Correction: Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
por: Bapat, Aditi S., et al.
Publicado: (2023)

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023)

Correction: Association between PARP-1 V762A Polymorphism and Breast Cancer Susceptibility in Saudi Population
Publicado: (2014)

Correction: Loss of PARP-1 attenuates diabetic arteriosclerotic calcification via Stat1/Runx2 axis
por: Li, Peng, et al.
Publicado: (2020)

Correction: PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023)

Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
por: Färkkilä, Anniina, et al.
Publicado: (2020)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
Publicado: (2015)

Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
por: Eyre, Toby A.
Publicado: (2019)

HP9800 - HP2401 interface
por: Littlewood, R K
Publicado: (1977)

Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma
por: Ma, Heng, et al.
Publicado: (2022)

Correction to: Risk factors associated with academic difficulty in an Australian regionally located medical school
por: Malau-Aduli, Bunmi S., et al.
Publicado: (2018)

Correction to: Prediction of pathogenesis-related secreted proteins from Stemphylium lycopersici
por: Zeng, Rong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2hvuvnr7g8pvukfs701qjo95s1